Other wealthy countries, they negotiate to get a better deal for their citizens. Our Congress banned that, and the result was predictable. American seniors ended up paying more than patients almost anywhere else. But the congressman who led the charge to protect Big Pharma, Billy Tauzen. He left Congress right after the bill passed to run one of the pharmaceutical industry's biggest lobbying powerhouses, earning more than 2 million a year. (02:41–02:46)
CLAIM
Asserts that U.S. seniors pay more for medications compared to seniors in other countries.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
